Are We Measuring the Right Biology in Chronic Obstructive Pulmonary Disease?

Your details

I register for the webinar. (Participant names are not shared with other viewers.)

The Extracellular Matrix Pharmacology Congress and its industry partner, Nordic Bioscience ApS, can contact me by email with news on research, events, products, and similar. I can always withdraw my consent at any time.

Date and time

Tuesday

April

17:00 CEST

Confirm sign-up

Are We Measuring the Right Biology in Chronic Obstructive Pulmonary Disease?

From Heterogeneity to Biology: ECM Remodeling and Precision Trials in Chronic Obstructive Pulmonary Disease

Join our webinar to explore whether current approaches truly capture the underlying biology of chronic obstructive pulmonary disease (COPD). This session focuses on extracellular matrix (ECM) remodeling as a central disease mechanism, its role in disease heterogeneity, and how ECM-derived biomarkers may support precision trials and improved prognostic assessment.

Learn more

Format
60-70 minutes presentation followed by 20-30 minutes of audience Q&A.

Agenda
Welcome and introduction

COPD heterogeneity and extracellular matrix remodeling as a core disease mechanism

ECM biomarkers as tools for disease activity and prognosis – Assessing critical pathways of disease

From COPD to Lung Cancer – The ECM as a pro-tumor environment

Speakers
Coming soon!

Expected duration
90 minutes

Share this webinar